Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
HZNP

Horizon Pharma

$18.82

-0.02 (-0.11%)

06:25
09/24/18
09/24
06:25
09/24/18
06:25
Recommendations
Horizon Pharma analyst commentary at Piper Jaffray »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 27

    Nov

Over a week ago
HZNP

Horizon Pharma

$21.14

0.48 (2.32%)

07:05
09/04/18
09/04
07:05
09/04/18
07:05
Hot Stocks
Horizon Pharma completes enrollment of Phase 3 trial of teprotumumab »

Horizon Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

Over a month ago
HZNP

Horizon Pharma

$20.91

0.79 (3.93%)

06:09
08/10/18
08/10
06:09
08/10/18
06:09
Recommendations
Horizon Pharma analyst commentary at Mizuho »

Horizon Pharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$20.12

1.97 (10.85%)

08:25
08/09/18
08/09
08:25
08/09/18
08:25
Recommendations
Horizon Pharma analyst commentary at Jefferies »

Horizon Pharma target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$18.15

0.16 (0.89%)

07:07
08/08/18
08/08
07:07
08/08/18
07:07
Earnings
Horizon Pharma continues to see FY18 revenue $1.17B-$1.2B, consensus $1.17B »

The company increased its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

HZNP

Horizon Pharma

$18.15

0.16 (0.89%)

07:06
08/08/18
08/08
07:06
08/08/18
07:06
Earnings
Horizon Pharma reports Q2 adjusted EPS 48c, consensus 31c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

HZNP

Horizon Pharma

$17.97

-0.21 (-1.16%)

04:54
08/06/18
08/06
04:54
08/06/18
04:54
Downgrade
Horizon Pharma rating change at BMO Capital »

Horizon Pharma downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

HZNP

Horizon Pharma

$17.26

-0.32 (-1.82%)

07:12
07/25/18
07/25
07:12
07/25/18
07:12
Recommendations
Horizon Pharma analyst commentary at Cantor Fitzgerald »

Horizon Pharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

HZNP

Horizon Pharma

$16.90

-0.175 (-1.02%)

08:33
07/16/18
07/16
08:33
07/16/18
08:33
Hot Stocks
Horizon Pharma receives two patents for Ravicti Oral Liquid »

Horizon Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

HZNP

Horizon Pharma

$16.81

0.04 (0.24%)

06:26
07/05/18
07/05
06:26
07/05/18
06:26
Recommendations
Horizon Pharma analyst commentary at Mizuho »

Horizon Pharma may be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.